December 11, 2018
A review by the ADDF published in Neurology® explores novel approaches beyond the common amyloid that could slow or prevent Alzheimer's.
September 24, 2018
Researchers shared updates on their approaches to developing Alzheimer's treatments at our annual conference.
September 17, 2018
Michele Gallagher, PhD, is the recipient of the fourth Melvin R. Goodes Prize, which includes a $150,000 award to support the therapeutic development of AGB-101.
September 13, 2018
The Alzheimer's Drug Discovery Foundation (ADDF) announces funding for a novel biomarker and two Phase I clinical studies.
July 13, 2018
The Alzheimer's Drug Discovery Foundation (ADDF) announces seven new investments, including clinical trials, novel drug programs, and a prevention program, which reflects the comprehensive nature of the ADDF's funding strategy.
May 10, 2018
We announce $2.5 million in new funding, which reflects the comprehensive nature of our strategy to prevent and treat Alzheimer’s disease.
May 4, 2018
Learn about clinical trials, an important and growing part of our funding at the Alzheimer’s Drug Discovery Foundation.
March 14, 2018
ADDF-supported research was at the forefront of the Summit and the National Plan to Address Alzheimer's.
January 30, 2018
For CTE Awareness Day, we highlight our support of diagnostic tools and treatments for this disease.
January 8, 2018
The ADDF announces nearly $1.8 million in new funding, which reflects our commitment to advancing drugs in or near human clinical trials.